Campath and Loratadine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Campath (alemtuzumab) and Loratadine (loratadine). Common drug interactions include headache among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Campath and Loratadine. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,315 Loratadine users. Check the latest studies of Loratadine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14 people who take Campath and Loratadine together, and have interactions are studied.

Campath and Loratadine drug interactions.

What are the common drug interactions of Campath and Loratadine, by gender? *:

female:

Headache (pain in head)
Urticaria (rash of round, red welts on the skin that itch intensely)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Drug administration error
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

male:

Headache (pain in head)
Hypotension (abnormally low blood pressure)
Chronic kidney disease
Drug administration error
Emotional distress
Fatigue (feeling of tiredness)
Foot fracture
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Mobility decreased (ability to move is reduced)
Pain

What are the common drug interactions of Campath and Loratadine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Headache (pain in head)
Urticaria (rash of round, red welts on the skin that itch intensely)
Hypotension (abnormally low blood pressure)
Drug administration error
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

30-39:

n/a

40-49:

Foot fracture
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Mobility decreased (ability to move is reduced)
Pain
Renal failure (kidney dysfunction)
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Blood creatinine increased

50-59:

n/a

60+:

Febrile neutropenia (fever with reduced white blood cells)
Pneumonia

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 78.57%
Headache (pain in head): 5 people, 35.71%
Rashes (redness): 2 people, 14.29%
Hiv Infection: 2 people, 14.29%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and Loratadine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously